AKT1 and cancer: In addition, GSEA revealed that the ERFEhigh status was associated with the enrichment of the G protein coupled receptor (GPCR) and PI3K-AKT pathways that are frequently overactivated in cancers and support tumor cell survival, proliferation, and invasion [31,32,33].